sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> in vitro diagnostics ivd quality control market

report

In Vitro Diagnostics (IVD) Quality Control Market, by Product and Services (Quality Control Products, Data Management Solutions, Quality Assurance Services), Application (Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, Microbiology, Other Applications), End User (Hospitals, Laboratories, Research Institutes and Academic Institutes, Other End Users), Manufacturer Type (Third-party Control Manufacturers, OEMs) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC365 September 2017 100+ FREE 10% CUSTOMIZATION

There is growth in the global market for IVD owing to various factors including the increasing number of accredited clinical laboratories and growing adoption of third-party quality controls to ensure unbiased test results. Moreover, the increasing use of multi-analyte controls and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and lack of regulations are restraining the growth of the market. 

The report on the global In vitro diagnostics (IVD) quality control market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The global market for In Vitro Diagnostics (IVD) Quality Control is fueled by various factors such as increasing no. of clinical laboratories, rising adoption of quality control of third party and escalating market demand for support of external quality assessment.
  • However, extra costing of IVD and constraint budget in laboratories and hospitals as well as unfavorable scenario of IVD test reimbursement are few hindering factors of global the In Vitro Diagnostics (IVD) Quality Control market. Also, one major opportunity occurring in the global In Vitro Diagnostics (IVD) Quality Control market is the growing market demand for multi-analyte controls.
  • On the other hand, strict process of product approval and lack of regulations that are mandatory for accreditation clinical laboratory in various emerging economies are the major challenges in the global market for In Vitro Diagnostics (IVD) Quality Control.

Regionally, the global In Vitro Diagnostics (IVD) Quality Control market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, North America is anticipated to be the market leader in the global market for In Vitro Diagnostics (IVD) Quality Control in the years to come. Several economies such as Canada and the US in this region are observing growing market demand for In Vitro Diagnostics (IVD) Quality Control. This market is Asia-Pacific and European regions is anticipated to observe high growth.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s in vitro diagnostics (IVD) quality control market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the in vitro diagnostics (IVD) quality control market by the following segments:

  • In Vitro Diagnostics (IVD) Quality Control Market, by Product and Service
    • Quality Control Products
    • Data Management Solutions
    • Quality Assurance Services
  • In Vitro Diagnostics (IVD) Quality Control Market, by Application
    • Clinical Chemistry
    • Immunochemistry
    • Hematology
    • Molecular Diagnostics
    • Coagulation/Hemostasis
    • Microbiology
    • Other Applications
  • In Vitro Diagnostics (IVD) Quality Control Market, by End User
    • Hospitals
    • Laboratories
    • Research Institutes and Academic Institutes
    • Other End Users
  • In Vitro Diagnostics (IVD) Quality Control Market, by Manufacturer Type
    • Third-party Control Manufacturers
    • OEMs

KEY MARKET PLAYERS

Key players in the in vitro diagnostics (IVD) quality control market include:

  • Roche Diagnostics
  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Helena Laboratories
  • Seracare Life Sciences, Inc.
  • Sero as
  • Randox Laboratories Ltd.
  • Siemens AG
  • Technopath Clinical Diagnostics
  • Ortho Clinical Diagnostics, Inc.
  • Sun Diagnostics, LLC

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

In-Vitro Diagnostics (IVD) Market, by Products (Instruments & Systems and Reagents & Consumables Segments), Applications (Immunochemistry, Clinical Chemistry, Hematology, Infectious Disease, Microbiology, Genetic Testing, and Histology & Cytology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2021


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
  5. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT AND SERVICE
    1. Segment Share
    2. By Product and Services
      1. Quality Control Products
      2. Data Management Solutions
      3. Quality Assurance Services
  6. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION
    1. Segment Share
    2. By Application
      1. Clinical Chemistry
      2. Immunochemistry
      3. Hematology
      4. Molecular Diagnostics
      5. Coagulation/Hemostasis
      6. Microbiology
      7. Other Applications
  7. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER
    1. Segment Share
    2. By End User
      1. Hospitals
      2. Laboratories
      3. Research Institutes and Academic Institutes
      4. Other End Users
  8. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY MANUFACTURER TYPE
    1. Segment Share
    2. By Manufacturer Type
      1. Third-party Control Manufacturers
      2. OEMs
  9. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Product and Services
      3. By Application
      4. By End User
      5. By Manufacturer Type
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Product and Services
      3. By Application
      4. By End User
      5. By Manufacturer Type
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Product and Services
      3. By Application
      4. By End User
      5. By Manufacturer Type
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Product and Services
      3. By Application
      4. By End User
      5. By Manufacturer Type
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  11. KEY MARKET PLAYERS
    1. Roche Diagnostics
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Abbott Laboratories Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Thermo Fisher Scientific Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Helena Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Seracare Life Sciences, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Sero as
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Randox Laboratories Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Siemens AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Technopath Clinical Diagnostics
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Ortho Clinical Diagnostics, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    11. Sun Diagnostics, LLC
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us